These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18848874)

  • 1. Characterisation and aerosolisation of mannitol particles produced via confined liquid impinging jets.
    Tang P; Chan HK; Chiou H; Ogawa K; Jones MD; Adi H; Buckton G; Prud'homme RK; Raper JA
    Int J Pharm; 2009 Feb; 367(1-2):51-7. PubMed ID: 18848874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
    Kaialy W; Martin GP; Ticehurst MD; Momin MN; Nokhodchi A
    Int J Pharm; 2010 Jun; 392(1-2):178-88. PubMed ID: 20363301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol dispersion of respirable particles in narrow size distributions produced by jet-milling and spray-drying techniques.
    Louey MD; Van Oort M; Hickey AJ
    Pharm Res; 2004 Jul; 21(7):1200-6. PubMed ID: 15290860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols.
    Chew NY; Chan HK
    Pharm Res; 1999 Jul; 16(7):1098-103. PubMed ID: 10450937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler.
    Kaialy W; Momin MN; Ticehurst MD; Murphy J; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Sep; 79(2):345-56. PubMed ID: 20537870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constant size, variable density aerosol particles by ultrasonic spray freeze drying.
    D'Addio SM; Chan JG; Kwok PC; Prud'homme RK; Chan HK
    Int J Pharm; 2012 May; 427(2):185-91. PubMed ID: 22322208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of powder polydispersity on aerosol generation.
    Chew NY; Chan HK
    J Pharm Pharm Sci; 2002; 5(2):162-8. PubMed ID: 12207868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can low-dose combination products for inhalation be formulated in single crystalline particles?
    Kumon M; Kwok PC; Adi H; Heng D; Chan HK
    Eur J Pharm Sci; 2010 Apr; 40(1):16-24. PubMed ID: 20172026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation.
    Chiou H; Li L; Hu T; Chan HK; Chen JF; Yun J
    Int J Pharm; 2007 Feb; 331(1):93-8. PubMed ID: 17052870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
    Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
    J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particle size dependence of polymorphism in spray-dried mannitol.
    Lee YY; Wu JX; Yang M; Young PM; van den Berg F; Rantanen J
    Eur J Pharm Sci; 2011 Sep; 44(1-2):41-8. PubMed ID: 21699976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimisation of powders for pulmonary delivery using supercritical fluid technology.
    Rehman M; Shekunov BY; York P; Lechuga-Ballesteros D; Miller DP; Tan T; Colthorpe P
    Eur J Pharm Sci; 2004 May; 22(1):1-17. PubMed ID: 15113578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine.
    Najafabadi AR; Gilani K; Barghi M; Rafiee-Tehrani M
    Int J Pharm; 2004 Nov; 285(1-2):97-108. PubMed ID: 15488683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers.
    Glover W; Chan HK; Eberl S; Daviskas E; Verschuer J
    Int J Pharm; 2008 Feb; 349(1-2):314-22. PubMed ID: 17904774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.